C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2006
12/21/2006	US20060286575 MCL-1 quadruplex nucleic acids and uses thereof
12/21/2006	US20060286572 Method for producing chemically synthesized and in vitro enzymatically synthesized nucleic acid oligomers
12/21/2006	US20060286568 Analyzing nucleic acid sample for a deletion in nucleotide sequence; sequencing a portion of the spinocerebellar ataxia type 5 (SCA5) polynucleotide; neurodegenerative diseases; diagnosis; hybridization
12/21/2006	US20060286565 assaying the level of RNA transcripts of gene sets in tissue samples, the expression of which is important in the diagnosis and/or prognosis of cancer, in particular of breast cancer
12/21/2006	US20060286564 Modified Pol III replicases and uses thereof
12/21/2006	US20060286561 Propargylethoxyamino nucleotides
12/21/2006	US20060286558 Normalization of samples for amplification reactions
12/21/2006	US20060286552 Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence
12/21/2006	US20060286124 Vaccine compositions and methods of treating coronavirus infection
12/21/2006	US20060286122 Modulation of angiogenesis by Bartonella henselae
12/21/2006	US20060286118 Lawsonia intracllularis subunit vaccine
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
12/21/2006	US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
12/21/2006	US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006	US20060286102 Cell surface receptor isoforms and methods of identifying and using the same
12/21/2006	US20060286093 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting ztnf4 activity
12/21/2006	US20060286087 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
12/21/2006	US20060286074 Methods for immunotherapy of cancer
12/21/2006	US20060286073 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
12/21/2006	US20060286035 Methods and compositions for modulating the interaction between adiponectin and its receptor
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	CA2611512A1 Methods for synthesis of encoded libraries
12/21/2006	CA2611198A1 Methods for the selection of aptamers
12/21/2006	CA2578844A1 Semi-soft c-class immunostimulatory oligonucleotides
12/20/2006	EP1734134A2 A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
12/20/2006	EP1734117A1 Novel fluorescent protein and gene encoding the same
12/20/2006	EP1733056A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
12/20/2006	EP1733051A2 Method and biomarkers for detecting tumor endothelial cell proliferation
12/20/2006	EP1733045A1 Design and therapeutic use of adpase enhanced apyrases
12/20/2006	EP1733037A2 Process for producing polypeptides
12/20/2006	EP1733035A2 Modified polynucleotides for reducing off-target effects in rna interference
12/20/2006	EP1733034A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
12/20/2006	EP1732946A2 Dimeric fusion proteins and materials and methods for producing them
12/20/2006	EP1732941A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
12/20/2006	EP1732940A2 METHOD FOR CONSTRUCTION AND USE OF <i>KLUYVEROMYCES LACTIS</i> PROMOTER VARIANTS IN <i>K.LACTIS</i> THAT SUBSTANTIALLY LACK <i>E. COLI</i> TRANSCRIPTIONAL CAPABILITY
12/20/2006	EP1732939A2 Nucleic acid based assays for identification of fc receptor polymorphisms
12/20/2006	EP1732608A2 Folate conjugates and complexes
12/20/2006	EP1732596A2 Therapeutic use of rm1 antigen
12/20/2006	EP1732571A2 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics
12/20/2006	EP1732382A2 Sfec, a sperm flagellar energy carrier protein
12/20/2006	EP1660687A4 Rnai-based modification of heterochromatin
12/20/2006	EP1472348B1 Ultraviolet light for light activated gene transduction in gene delivery
12/20/2006	EP1147123B1 Novel odorant receptors in drosophila
12/20/2006	CN2848877Y 快速核酸电泳槽 Rapid DNA electrophoresis tank
12/20/2006	CN1882699A Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
12/20/2006	CN1882605A Improved expression systems using Sec-system secretion
12/20/2006	CN1882604A Genetic markers for obesity
12/20/2006	CN1882603A mRNA transfected antigen presenting cells
12/20/2006	CN1882602A The moduilation of hyaluronan synthesis and degradation in the treatment of disease
12/20/2006	CN1880332A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1880331A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1880330A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1880329A Reversible packaging micro fluent chip for separating and purifying biological sample
12/20/2006	CN1291034C Method for identifying polynucleotide
12/20/2006	CN1290861C New type human bone marrow stroma cell source 1 type phosphatase inhibition factor, its coded sequence and use
12/20/2006	CN1290855C Nucleotide analogs with six-membered rings
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7151171 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
12/19/2006	US7151168 Induction, controlling gene expression; genetic engineered plants
12/19/2006	US7151164 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
12/19/2006	US7151162 Capable of interacting with wnt-signalling pathway (beta-catenins and T-cell factors); cancer diagnosis
12/19/2006	US7151160 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	US7150976 Regulation of human serine-threonine protein kinase
12/19/2006	US7150970 RNA molecules (e.g., antisense, RNAi, or siRNA) specific for VEGF-C
12/19/2006	US7150969 Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
12/19/2006	US7150968 Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor
12/19/2006	US7150967 Uisng fluorescent label; mercurimethyl dihydropsoralen
12/19/2006	US7150966 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence
12/19/2006	US7150875 Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine
12/19/2006	US7150873 Hydrophilic eimeria polypeptide; genetic engineering
12/19/2006	US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/19/2006	US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006	US7150856 On-spot selectively activated hydrophobic slide and preparation thereof
12/19/2006	CA2478020C Quantitative assay for the simultaneous detection and speciation of bacterial infections
12/19/2006	CA2297547C An improved method for preparing dna from serum and plasma
12/19/2006	CA2251169C Quaternary cytofectins
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/16/2006	CA2512492A1 Methods and reagents for inhibiting cell proliferation
12/14/2006	WO2006133210A2 Mannitol induced promoter systems in bacterial host cells
12/14/2006	WO2006132607A1 Mutant allergen(s)
12/14/2006	WO2006132588A1 Method for the purification of synthetic oligonucleotides containing one or several labels
12/14/2006	WO2006132555A1 Peramine biosynthesis
12/14/2006	WO2006132204A1 Transcription factor decoy
12/14/2006	WO2006130976A1 Interfering rnas, methods for their production, and use
12/14/2006	WO2006105486A3 Novel tumor suppressor gene and compositions and methods for making and using the same
12/14/2006	WO2006085961A3 Anti-mcp-1 antibodies, compositions, methods and uses
12/14/2006	WO2006074216A3 Identification of molecular interactions and therapeutic uses thereof
12/14/2006	WO2006060257A3 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
12/14/2006	WO2006017355A3 Improved aprotinin variants
12/14/2006	WO2005115444A3 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
12/14/2006	WO2005113571A3 Methods for the delivery of oligomeric compounds
12/14/2006	WO2005084272A3 Nucleic acid complexes
12/14/2006	WO2003033722A3 Nucleic acid amplification methods
12/14/2006	US20060282921 Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells
12/14/2006	US20060282919 Nucleic acid that drives pollen-specific expression; down- or up-regulation of gene expression in pollen; producing a plant with reduced male fertility
12/14/2006	US20060282916 Genes controlling plant cell wall formation

1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 899